Disease/Infection News

RSS

Cannabis compound inhibits SARS-CoV-2 replication in human lung cells

Researchers in the United States have conducted a study showing that a cannabis plant compound inhibited infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human lung cells.

14 Mar 2021

Researchers investigate digital contact tracing's ability to reduce the spread of COVID-19

Informing how COVID-19 response plans may incorporate digital contact tracing, a model of COVID-19 spread within a simulated French population found that if about 20% of the population adopted a contact tracing app on their smartphones, an outbreak could be reduced by about 35%. If more than 30% of the population adopted the app, the epidemic could be suppressed to manageable levels.

13 Mar 2021

Pragmatic recommendations for management of COVID-19 in low- and middle-income countries

A new supplement offering guidance on severe COVID-19 management in resource-limited settings is now available on the American Journal of Tropical Medicine website.

13 Mar 2021

Study finds visual correlation between severity of COVID-19 in the lungs and brain

Since the pandemic hit, researchers have been uncovering ways COVID-19 impacts other parts of the body, besides the lungs.

13 Mar 2021

New vaccination method aims at comprehensive protection against all known influenza mutations

One shot, protected forever: This would be a dream come true regarding influenza vaccinations. So far, vaccination against influenza did not provide a lasting protection.

13 Mar 2021

Research provides a new cornerstone of malaria's evolution with humans

New bioarchaeological research shows malaria has threatened human communities for more than 7000 years, earlier than when the onset of farming was thought to have sparked its devastating arrival.

13 Mar 2021

Could horse-derived antibodies promote immunity against SARS-CoV-2 infection?

Researchers based in India have demonstrated that horses inoculated with an inactivated dosage of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are able to produce large amounts of strong antibodies that can neutralize multiple variants

12 Mar 2021

Single-dose vaccines may provide sufficient immunization for individuals previously infected with SARS-CoV-2

A group of researchers based at the Papa Giovanni XXIII hospital in Italy have submitted evidence to suggest that individuals previously infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may adequately benefit from a single dose of mRNA vaccine, rather than requiring the current two-vaccine regimen.

12 Mar 2021

An overview of the BNT162b2 COVID-19 vaccine by Pfizer-BioNTech

In a study published in the journal Drugs, a researcher tackled the approval of Pfizer-BioNTech’s COVID-19 vaccine, which has now been used in many countries.

12 Mar 2021

Study identifies three novel binding receptors for SARS-CoV-2

A team of scientists from the United Kingdom recently conducted a large-scale screening of several membrane-bound and soluble host cell receptors to identify novel binding partners for SARS-CoV-2. They have identified three novel receptors expressed on the human cell membrane; of which, one binds to SARS-CoV-2 spike with similar affinity as angiotensin-converting enzyme 2 (ACE2).

12 Mar 2021

How common are post-acute sequelae of SARS-CoV-2 infection?

The COVID-19 pandemic has taken a heavy toll on human lives, with over two million casualties so far. Equally devastating has been its economic toll. Now, a new study describes the features and frequency of long-haul symptoms in COVID-19.

12 Mar 2021

Natural virus-induced immunity protective against UK and South African SARS-CoV-2 variants in hamster study

As new variants of SARS-CoV-2 continue to emerge, fueling the continued spread of the COVID-19 pandemic, a new study offers encouragement.

12 Mar 2021

Impact of type I interferon (IFN) autoantibodies in critical COVID-19

A new preprint discusses the pathogenesis of this critical COVID-19 with reference to autoimmune phenomena involving the key antiviral type I interferon pathway.

12 Mar 2021

Antibodies to SARS-CoV-2 spike protein and RBD detected in saliva of mRNA-vaccine recipients

A team of researchers from the US and the Netherlands recently reported that antibodies to the spike protein and the RBD are detected in saliva samples from healthcare workers vaccinated with mRNA vaccines.

12 Mar 2021

SARS-CoV-2 is extremely sensitive to type I IFN pre-treatment, study finds

Researchers have found that SARS-CoV-2 is extremely sensitive to type I IFN pre-treatment. Therefore, strategies such as focusing on limiting the production of IFN, rather than its function, could restrict the mechanism of SARS-CoV-2 that increases its viral load with delayed or absent symptoms.

12 Mar 2021

Pooling COVID-19 tests to detect future outbreaks

How could pooling SARS-CoV-2 tests help to detect future viral outbreaks? News-Medical spoke to Dr. Jean-François Rupprecht to find out more.

12 Mar 2021

U.S. Congress has clear opportunity to supercharge global health R&D, shows report

The U.S. Congress and Biden-Harris administration have a clear opportunity to supercharge global health research and development (R&D) in the wake of a pandemic that has revealed both the sector's chronic neglect and amazing potential.

12 Mar 2021

Tailored approach is required to fight antibiotic resistance

The global battle against antibiotic resistance can only succeed if local contexts are taken into account. "A tailored approach is needed in each country," says Heiman Wertheim of Radboud university medical center. "There is no "one-size-fits-all' solution."

12 Mar 2021

New book provides general introduction about COVID-19, history, and diagnosis

Recently, a novel coronavirus (2019-nCoV) emerged in China and rapidly spread worldwide. It is declared an ongoing outbreak as a global public health emergency by the World Health Organization (WHO).

12 Mar 2021

Public schools can adopt lower physical distancing policies with masking mandates

As COVID-19 infection rates continue to fall, Massachusetts officials are signaling it's almost time to end remote learning and send all school-aged children back to the classroom.

12 Mar 2021

Disease/Infection News

Cannabis compound inhibits SARS-CoV-2 replication in human lung cells

Researchers investigate digital contact tracing's ability to reduce the spread of COVID-19

Pragmatic recommendations for management of COVID-19 in low- and middle-income countries

Study finds visual correlation between severity of COVID-19 in the lungs and brain

New vaccination method aims at comprehensive protection against all known influenza mutations

Research provides a new cornerstone of malaria's evolution with humans

Could horse-derived antibodies promote immunity against SARS-CoV-2 infection?

Single-dose vaccines may provide sufficient immunization for individuals previously infected with SARS-CoV-2

An overview of the BNT162b2 COVID-19 vaccine by Pfizer-BioNTech

Study identifies three novel binding receptors for SARS-CoV-2

How common are post-acute sequelae of SARS-CoV-2 infection?

Natural virus-induced immunity protective against UK and South African SARS-CoV-2 variants in hamster study

Impact of type I interferon (IFN) autoantibodies in critical COVID-19

Antibodies to SARS-CoV-2 spike protein and RBD detected in saliva of mRNA-vaccine recipients

SARS-CoV-2 is extremely sensitive to type I IFN pre-treatment, study finds

Pooling COVID-19 tests to detect future outbreaks

U.S. Congress has clear opportunity to supercharge global health R&D, shows report

Tailored approach is required to fight antibiotic resistance

New book provides general introduction about COVID-19, history, and diagnosis

Public schools can adopt lower physical distancing policies with masking mandates

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Automating research - solutions and best practices

Latest News